Health Care & Life Sciences » Pharmaceuticals | Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.56
Market Cap
$82.71 M
Shares Outstanding
16.44 M
Public Float
13.42 M

Profile

Address
35 Parkwood Drive
Hopkinton Massachusetts 01748
United States
Employees -
Website http://www.springbankpharm.com
Updated 07/08/2019
Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its pipeline include RIG-I & STING Agonists platforms. The company was founded by Douglas J.

Financials

View All
Created with Highcharts 5.0.14Spring Bank Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.6 9566 9569 7129 71211 56411 56417 36617 36627 67927 67922 85422 85420132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Spring Bank Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.6516517387389469463523520028828820132014201520162017201802505007501000

Martin J. Driscoll
Chairman, President & Chief Executive Officer
Radhakrishnan P. Iyer
Director & Chief Scientific Officer